Optimizing Adjuvant Care in Early Breast Cancer: Multidisciplinary Strategies and Innovative Models from Canadian Centers
Current Oncology · 14.07.2025 · 32 (7) · 402
DOI: 10.3390/curroncol32070402 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 14.07.2025. Verfasst von Angela Chan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, BC Cancer, University of British Columbia, Vancouver, BC V6T 1Z3, Canada. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novartis (Canada), Novartis Pharmaceuticals Canada Inc..
Abstract (Originalsprache)
The adjuvant treatment landscape for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) early breast cancer (EBC) is rapidly evolving, with a diverse range of therapeutic options—including endocrine therapies, bisphosphonates, ovarian function suppression, olaparib, CDK4/6 inhibitors, and emerging agents such as immunotherapy. While these advances have markedly improved patient outcomes, they also introduce challenges related to implementation, monitoring, and resource allocation. Notably, therapies like CDK4/6 inhibitors require particularly close monitoring, creating logistical and capacity challenges for medical oncologists, whose workloads are already stretched due to rising cancer incidence and treatment complexities. These challenges underscore the need for innovative care delivery solutions to ensure patients with EBC continue to receive optimal care. This paper offers a comprehensive guide—a playbook—of multidisciplinary-team-based care models designed to optimize adjuvant treatment delivery in EBC. Drawing on real-world evidence and successful applications across Canadian centers, we explore models led by nurses, nurse practitioners (NPs), general practitioners in oncology (GPO), and pharmacists. Each model leverages the unique expertise of its team to manage treatment toxicities, facilitate adherence, and enhance patient education, thereby promoting effective and sustainable care delivery. Importantly, these models are not intended to compete with one another, but rather to serve as a flexible recipe book from which breast cancer care teams can draw strategies tailored to their local resources and patient needs. By detailing implementation strategies, benefits, and challenges—in many instances supported by quantitative metrics and economic evaluations—this work aims to inspire care teams nationwide to optimize the adjuvant management of patients with HR+, HER2– EBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, BC Cancer, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
- Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 2T8, Canada.
- Odette Cancer Centre, Sunnybrook Health Science Centre, University of Toronto, Toronto, ON M4N 3M5, Canada.
- Faculté de Médecine, Université de Montréal, Montreal, QC H3T 1J4, Canada.
- Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB T2N 5G2, Canada.
- Department of Medical Oncology, Windsor Regional Hospital, Windsor, ON N8W 1L9, Canada.
ORCID-Profile: Muna Al-Khaifi, Caroline Hamm, Thomas Joly-Mischlich, Mita Manna, Tom McFarlane, Laura V Minard, Sarah Naujokaitis
Förderung
- Novartis (Canada)
- Novartis Pharmaceuticals Canada Inc.
Zitieren
APA
Chan, A., Nixon, N., Al-Khaifi, M., Bestavros, A., Blyth, C., Cheung, W. Y., Hamm, C., Joly-Mischlich, T., Manna, M., McFarlane, T., Minard, L. V., Naujokaitis, S., Peragine, C., Railton, C., & Edwards, S. (2025). Optimizing Adjuvant Care in Early Breast Cancer: Multidisciplinary Strategies and Innovative Models from Canadian Centers. Current Oncology, 32(7), 402. https://doi.org/10.3390/curroncol32070402
Vancouver
Chan A, Nixon N, Al-Khaifi M, Bestavros A, Blyth C, Cheung WY, et al. Optimizing Adjuvant Care in Early Breast Cancer: Multidisciplinary Strategies and Innovative Models from Canadian Centers. Current Oncology. 2025;32(7):402. doi:10.3390/curroncol32070402
BibTeX
@article{Chan2025,
author = {Chan, Angela and Nixon, Nancy and Al-Khaifi, Muna and Bestavros, Alain and Blyth, Christine and Cheung, Winson Y and Hamm, Caroline and Joly-Mischlich, Thomas and Manna, Mita and McFarlane, Tom and Minard, Laura V and Naujokaitis, Sarah and Peragine, Christine and Railton, Cindy and Edwards, Scott},
title = {Optimizing Adjuvant Care in Early Breast Cancer: Multidisciplinary Strategies and Innovative Models from Canadian Centers},
journal = {Current Oncology},
year = {2025},
volume = {32},
number = {7},
pages = {402},
doi = {10.3390/curroncol32070402}
}
EUVIMED